Unravelling the dynamics of selection of multiresistant variants to integrase inhibitors in an HIV-1-infected child using ultra-deep sequencing
Author(s) -
Karl Stéfic,
Maud Salmona,
Marisa Capitao,
Marion Splittgerber,
Z. Maakaroun-Vermesse,
MarieLaure Nere,
Louis Bernard,
MarieLaure Chaix,
Francis Barin,
Constance Delaugerre
Publication year - 2016
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkw507
Subject(s) - raltegravir , dolutegravir , elvitegravir , sanger sequencing , integrase , genetics , biology , integrase inhibitor , mutant , gene , mutation , virology , antiretroviral therapy , virus , viral load
Ultra-deep sequencing (UDS) allows detection of minority resistant variants (MRVs) with a threshold of 1% and could be useful to identify variants harbouring single or multiple drug-resistance mutations (DRMs).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom